SCL vs IOSP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SCL · Stepan$63.48 ▼ 2.34%
IOSP · Innospec$75.56 ▼ 1.97%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SCL +54.9%
- IOSP +12.3%
Head to head
| Metric | SCL | IOSP |
|---|---|---|
| Price | $63.48 | $75.56 |
| Change today | ▼ 2.34% | ▼ 1.97% |
| Market cap | $1.44B | $1.86B |
| Return, 3 months | +2.8% | -18.7% |
| Return, year to date | +37.0% | -0.1% |
| Return, 1 year | +48.3% | +7.9% |
| P/E (TTM) | 334.1 | 13.3 |
| P/B | 1.2 | 1.4 |
| P/E percentile vs own 5y | 99th | 6th |
| Dividend yield | 2.49% | 2.37% |
| Revenue growth (YoY, latest qtr) | +17.3% | +7.2% |
| Net profit growth (YoY) | +64.3% | +148.8% |
| Gross margin | 12.0% | 27.7% |
| Operating margin | 3.6% | 8.5% |
| Net margin | 0.2% | 7.5% |
| Return on equity | 0.4% | 10.5% |
| Analyst target vs. price | +33.9% | +45.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 41 | 30 |
| 30-day volatility | 28.2% | 63.4% |
| Max drawdown, 1 year | -32.8% | -25.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IOSP is the largest of the group by market value.
- SCL has returned the most over the past year.
- IOSP carries the lowest trailing P/E.
- SCL pays the highest dividend yield.
- SCL is growing revenue fastest.
- IOSP keeps the most profit per dollar of sales.
- SCL has been the calmest stock over the last 30 days.